TENOMIX INC.
$200,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- April 1, 2024 – March 17, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q2-1021809
Published purpose
In colorectal cancer, staging is crucial for patient survival. Current healthcare systems often fail at accurate staging, leading to poor outcomes and higher costs. The process requires manually searching for lymph nodes (LNs) in tissues removed during surgery, a task that is time-consuming (30 mins to over 2 hours), expensive, and often misses small LNs, risking incorrect treatment. To solve this problem, Tenomix is developing a platform combining robotics, ultrasound, and AI to automate LN detection, making the process quicker, cheaper, and more accurate. This will aid pathology labs and improve treatment decisions. The current project focuses on advancing this technology, preparing for regulatory filing in 2025.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.